← Eichor
Study identifier: NCT07705191 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of SugarLock® Peanut Skin Extract on Postprandial Blood Glucose Control

Condition: Blood Sugar (Glucose) Control · Postprandial Glucose  ·  Sponsor: TCI Co., Ltd.

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The objective of this study is to investigate the effects of pre-meal supplementation with SugarLock® peanut skin extract and white kidney bean extract on reducing or delaying postprandial blood glucose elevation and glycemic fluctuations, and to evaluate their potential as nutritional supplements for postprandial glycemic management.

This description comes directly from the study's public registry record.

Talk to the study team

Fang-Pei Chen, Ph.D.  ·  +886-06-2785123  ·  fpchen@mail.cjcu.edu.tw

Always discuss trial participation with your own doctor first.

Locations (1)

Chang Jung Christian UniversityTainan, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07705191